[HTML][HTML] Dual therapy treatment strategies for the management of patients infected with HIV: a systematic review of current evidence in ARV-naive or ARV-experienced …
JG Baril, JB Angel, MJ Gill, J Gathe, P Cahn… - PLoS …, 2016 - journals.plos.org
Objective We reviewed the current literature regarding antiretroviral (ARV)-sparing therapy
strategies to determine whether these novel regimens can be considered appropriate …
strategies to determine whether these novel regimens can be considered appropriate …
Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease
SD Aaron, JB Angel, M Lunau, K Wright… - American journal of …, 2001 - atsjournals.org
There is increasing evidence that chronic obstructive pulmonary disease (COPD) is associated
with chronic inflammation in the airways and lung parenchyma; however, little is known …
with chronic inflammation in the airways and lung parenchyma; however, little is known …
A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses.
…, E Vannier, G Lonnemann, JB Angel… - … (Baltimore, Md.: 1950 …, 1995 - journals.aai.org
In vitro, IL-10 inhibits T cell proliferation and LPS-induced monocyte production of IL-1, TNF-alpha,
IL-6, and IL-8. We studied the safety and immunomodulatory effects of IL-10 …
IL-6, and IL-8. We studied the safety and immunomodulatory effects of IL-10 …
[HTML][HTML] Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity?
CT Costiniuk, JB Angel - Mucosal immunology, 2012 - Elsevier
While only partial immune reconstitution in gut-associated lymphoid tissue typically occurs
following initiation of highly active antiretroviral therapy (HAART) in human immunodeficiency …
following initiation of highly active antiretroviral therapy (HAART) in human immunodeficiency …
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority …
…, Y Yazdanpanah, D Podzamczer, T Lutz, JB Angel… - The Lancet, 2017 - thelancet.com
Background Cabotegravir and rilpivirine are antiretroviral drugs in development as long-acting
injectable formulations. The LATTE-2 study evaluated long-acting cabotegravir plus …
injectable formulations. The LATTE-2 study evaluated long-acting cabotegravir plus …
Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures
Sequence variants at or near the leucine-rich repeat kinase 2 (LRRK2) locus have been
associated with susceptibility to three human conditions: Parkinson's disease (PD), Crohn’s …
associated with susceptibility to three human conditions: Parkinson's disease (PD), Crohn’s …
CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults
CL Cooper, HL Davis, JB Angel, ML Morris, SM Elfer… - Aids, 2005 - journals.lww.com
Background: HIV patients are vaccine hyporesponsive. Methods: We evaluated CPG 7909,
a synthetic oligodeoxynucleotide containing immunostimulatory CpG motifs, as an adjuvant …
a synthetic oligodeoxynucleotide containing immunostimulatory CpG motifs, as an adjuvant …
[HTML][HTML] Fertility desires and intentions of HIV-positive women of reproductive age in Ontario, Canada: a cross-sectional study
…, M Muchenje, AR Rachlis, FM Smaill, JB Angel… - PloS one, 2009 - journals.plos.org
Background Improvements in life expectancy and quality of life for HIV-positive women
coupled with reduced vertical transmission will likely lead numerous HIV-positive women to …
coupled with reduced vertical transmission will likely lead numerous HIV-positive women to …
Ritonavir and saquinavir combination therapy for the treatment of HIV infection
…, D Poretz, M Markowitz, S Follansbee, JB Angel… - Aids, 1999 - journals.lww.com
Objective: To evaluate the safety and antiretroviral activity of ritonavir (Norvir TM) and saquinavir
(Invirase TM) combination therapy in patients with HIV infection. Design: A multicenter, …
(Invirase TM) combination therapy in patients with HIV infection. Design: A multicenter, …
Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B–immune patient: case report and review of the literature
A Kempinska, EJ Kwak, JB Angel - Clinical infectious diseases, 2005 - academic.oup.com
Background . Reactivation of hepatitis B virus (HBV) infection following allogeneic bone
marrow transplantation is a rare phenomenon. Methods . Reverse seroconversion, defined as …
marrow transplantation is a rare phenomenon. Methods . Reverse seroconversion, defined as …